Market Overview:
Bioactive peptides are short chains of amino acids that exert physiological effects in humans and other animals. They are found in various food proteins including collagen, casein, whey, soy, and eggs, and are released during digestion or food processing. These peptides have beneficial effects such as antimicrobial, antihypertensive (blood pressure lowering), antioxidant, anticancer, opioid, and immunomodulating properties, among others and help to improve gut health, metabolism, and cardiovascular health. Rising consumer awareness about healthy lifestyles and demand for functional food and beverages are boosting the demand for bioactive peptides in the market.
Market key trends:
One of the major trends in the bioactive peptide market is the increasing use of bioactive peptides for weight and appetite management. Bioactive peptides such as GLP-1, GLP-2, PYY, and oxyntomodulin are used to regulate appetite and food intake. These peptides mimic the body’s natural response to a meal, helping people feel fuller for longer. Additionally, bioactive peptides also enhance metabolism, fat oxidation, and thermogenesis. The growing prevalence of obesity is driving the demand for bioactive peptides in weight management products. Another important trend is the incorporation of bioactive peptides in sports nutrition and supplements as regular physical activity increases the rate of protein breakdown in muscles. Bioactive peptides help to build, maintain, and repair muscles after exercise and training.
The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Porter’s Analysis
Threat of new entrants: The bioactive peptide market requires high R&D investments and costs for clinical trials. These high entry barriers discourage new entrants in the market.
Bargaining power of buyers: The bioactive peptide market has numerous buyers including pharmaceutical companies, nutraceutical companies, and food and beverage manufacturers. However, their bargaining power is relatively low due to the niche and specialized nature of bioactive peptides.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are many players producing bioactive peptides. However, major suppliers have the advantage due to their expertise and experience.
The threat of new substitutes: There is a low threat of substitutes as bioactive peptides have distinct properties and are difficult to replicate, limiting the possibility of substitutes.
Competitive rivalry: The bioactive peptide market witnesses high competitive rivalry due to the presence of numerous global and regional players operating in this market.
Key Takeaways
The global bioactive peptide market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing demand for functional food and beverages. The global market size for bioactive peptides was valued at US$ 9.8 Mn in 2023.
Regional analysis: The North American region dominates the global bioactive peptide market due to growing health awareness and high consumption of dietary supplements in countries like the US and Canada. The Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to increasing incomes and health consciousness in developing countries of China and India.
Key players: Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
